Alphafetoprotein Testing
The alphafetoprotein (AFP) test is a screening test drawn from maternal blood usually between 15-17 weeks gestation to help find babies who suffer from neural tube defects (NTD) or Down Syndrome. Will you take this test?
Alphafetoprotein (AFP or triple) screening: Most women can expect to get AFP testing during their pregnancy.
Alphafetoprotein (AFP): Substance produced by the unborn baby as it grows inside the uterus. Large amounts of AFP are found in the amniotic fluid.
Alphafetoprotein (AFP) testing: The mother’s blood is tested during 15 to 17 weeks of gestation to detect possible neural-tube defects and Down Syndrome in the fetus.
Alphafetoprotein testing (AFP) is another option. This test measures the amount of AFP present in your blood. It is usually done between 16 - 18 weeks. It can detect such problems as spina bifida, anencephaly and possibly Down's Syndrome.
Alphafetoprotein (AFP) screening test. This tests helps to detect neural tube defects which affect the spine and brain of the fetus.
A blood test to screen for diabetes is done between weeks 24-28.
AFP, alphafetoprotein, screening is a prenatal blood test that checks AFP, hCG, and estridol levels with increased accuracy.
The test you describe is a simple blood test which can be evaluated for something called maternal serum alphafetoprotein (MSAFP). MSFAP is a protein made by the fetal yolk sac in early pregnancy and later on by the fetal liver.
 See also: Pregnancy, Pregnant, Ultrasound, Amnio, AFP
  
|
RSS
